Addex Therapeutics (ADXN) Operating Expenses (2022 - 2025)
Historic Operating Expenses for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$932274.2.
- Addex Therapeutics' Operating Expenses fell 1868.68% to -$932274.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 1137.59%. This contributed to the annual value of $3.6 million for FY2024, which is 1628.85% down from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' Operating Expenses is -$932274.2, which was down 1868.68% from -$929197.4 recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Operating Expenses peaked at $31.0 million during Q4 2022, and registered a low of -$7.6 million during Q2 2022.
- Its 4-year average for Operating Expenses is $1.2 million, with a median of -$940290.3 in 2023.
- The largest annual percentage gain for Addex Therapeutics' Operating Expenses in the last 5 years was 8554.27% (2023), contrasted with its biggest fall of 7512.93% (2023).
- Quarter analysis of 4 years shows Addex Therapeutics' Operating Expenses stood at $31.0 million in 2022, then plummeted by 75.13% to $7.7 million in 2023, then dropped by 12.86% to $6.7 million in 2024, then crashed by 113.88% to -$932274.2 in 2025.
- Its last three reported values are -$932274.2 in Q3 2025, -$929197.4 for Q2 2025, and -$753346.2 during Q1 2025.